Does Anemia Affect Outcome after Lobectomy or Pneumonectomy in Early Stage Lung Cancer Patients Who Have not Received Neo-Adjuvant Treatment?

Abstract

Backround: Preoperative anemia has been shown to be an ominous prognostic factor for survival in patients with early stage non small cell lung cancer. Methods: Two hundred and fourteen patients underwent resection for early stage non small cell lung cancer between 2001 and 2006 without neo-adjuvant treatment. Patients were divided into four groups based on their admission hemoglobin (Hgb): group I: Hgb ≤ 12 g/dl, group II: Hgb = 12.1 - 12.9 g/dl, group III: Hgb = 13.0 - 14.0 g/dl, and group IV: Hgb > 14 g/dl. Cox regression analysis was used to evaluate each variable's impact on midterm survival taking all causes and lung cancer-specific mortality into account. Kaplan-Meier survival plots were estimated. Results: Preoperative hemoglobin (HR = 1.44, 95 % confidence intervals 1.08 - 1.94, p = 0.014) and pneumonectomy (HR = 3.58, 95 % confidence intervals 1.26 - 10.16, p = 0.017) were the only predictors of all-cause midterm mortality. Similarly, when only lung cancer-related mortality was considered, preoperative hemoglobin (HR = 1.81, 95 % confidence intervals 1.17 - 2.78, p = 0.007) and pneumonectomy (HR = 6.89, 95 % confidence intervals 2.29 - 20.73, p = 0.001,) were independent predictors. Age, gender, pulmonary function test results, tumor stage, and histology did not influence survival. Conclusions: Preoperative anemia and the type of resection in early stage non small cell lung cancer have an impact on midterm survival and lung cancer-specific mortality.

Key words

anemia - non small cell lung cancer - neo‐adjuvant treatment - survival

References

• 1 Jemal A, Siegel R, Ward E. et al . Cancer statistics, 2006.  CA Cancer J Clin. 2006;  56 106-130
• 2 Pairolero P C, Williams D E, Bergstralh E J. et al . Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease.  Ann Thorac Surg. 1984;  38 331-338
• 3 Thomas P, Rubinstein L. Cancer recurrence after resection: T1 N0 non-small cell lung cancer. Lung Cancer Study Group.  Ann Thorac Surg. 1990;  49 242-246
• 4 Batevik R, Grong K, Segadal L, Stangeland L. The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: a study of absolute and relative survival over 15 years.  Lung Cancer. 2005;  47 173-181
• 5 Bouchardy C, Fioretta G, de Perrot M, Obradovic M, Spiliopoulos A. Determinants of long term survival after surgery for cancer of the lung: a population-based study.  Cancer. 1999;  86 2229-2237
• 6 Jazieh A R, Hussain M, Howington J A. et al . Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer.  Ann Thorac Surg. 2000;  70 1168-1171
• 7 Yovino S, Kwok Y, Krasna M, Bangalore M, Suntharalingam M. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.  Int J Radiat Oncol Biol Phys. 2005;  62 1438-1443
• 8 Williams B C, Demitrack L B, Fries B E. The accuracy of the National Death Index when personal identifiers other than Social Security number are used.  Am J Public Health. 1992;  82 1145-1147
• 9 Kaplan E L, Meier P. Nonparametric estimation from incomplete observations.  J Am Stat Assoc. 1958;  53 547-581
• 10 Cox D R. Regression models and life-tables.  J R Stat Soc. 1972;  34 187-220
• 11 Wigren T, Oksanen H, Kellokumpu-Lehtinen P. A practical prognostic index for inoperable non-small-cell lung cancer.  J Cancer Res Clin Oncol. 1997;  123 259-266
• 12 Harrison L B, Chadha M, Hill R J, Hu K, Shasha D. Impact of tumor hypoxia and anemia on radiation therapy outcomes.  Oncologist. 2002;  7 492-508
• 13 Weinstein D A, Roy C N, Fleming M D. et al . Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease.  Blood. 2002;  100 3776-3781
• 14 Beguin Y. Erythropoietin and the anemia of cancer.  Acta Clin Belg. 1996;  51 36-52
• 15 Paul I, Lappin T R, Maxwell P, Graham A N. Pre-operative plasma erythropoietin concentration and survival following surgery for non-small cell lung cancer.  Lung Cancer. 2006;  51 329-334
• 16 Tartter P I. The association of perioperative blood transfusion with colorectal cancer recurrence.  Ann Surg. 1992;  216 633-638
• 17 Sanfilippo F, Vaughn W K, Bollinger R R, Spees E K. The influence of pretransplant transfusions, using different blood products, on patient sensitization and renal allograft survival.  Transplantation. 1984;  37 350-356
• 18 Tobu M, Iqbal O, Fareed D. et al . Erythropoietin-induced thrombosis as a result of increased inflammation and thrombin activatable fibrinolytic inhibitor.  Clin Appl Thromb Hemost. 2004;  10 225-232
• 19 Aapro M, Coiffier B, Dunst J, Osterborg A, Burger H U. Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer: a meta-analysis.  Br J Cancer. 2006;  95 1467-1473
• 20 Bernet F, Brodbeck R, Guenin M O. et al . Age does not influence early and late tumor-related outcome for bronchogenic carcinoma.  Ann Thorac Surg. 2000;  69 913-918
• 21 Alexiou C, Beggs D, Onyeaka P. et al . Pneumonectomy for stage I (T1N0 and T2N0) non-small cell lung cancer has potent, adverse impact on survival.  Ann Thorac Surg. 2003;  76 1023-1028
• 22 Ferguson M K, Karrison T. Does pneumonectomy for lung cancer adversely influence long-term survival?.  J Thorac Cardiovasc Surg. 2000;  119 440-448
• 23 Alexiou C, Onyeaka C V, Beggs D. et al . Do women live longer following lung resection for carcinoma?.  Eur J Cardiothorac Surg. 2002;  21 319-325
• 24 Peduzzi P, Concato J, Kemper E, Holford T R, Feinstein A R. A simulation study of the number of events per variable in logistic regression analysis.  J Clin Epidemiol. 1996;  49 1373-1379